| 摘要 |
<p>The invention relates to dendrimer agents presenting polypetides providing the binding domain of a ß integrin subunit for an ERK MAP kinase, or a variant or modified form of the binding domain, and the use of the dendrimers to inhibit growth of cancer cells. The peptides present more that 8 units ofthepolypeptide(s)examples of which include the peptide RSKAKNPLYR (SEQ ID No. 6).</p> |
